---
title: "Prognostic Value of Serum Neurofilament Light Chain for Disease Activity and Worsening in Patients With Relapsing Multiple Sclerosis: Results From the Phase 3 ASCLEPIOS I and II Trials"
date: 2022-03-31
enddate:
---

Published in: *Frontiers in Immunology*

DOI: [10.3389/fimmu.2022.852563](https://doi.org/10.3389/fimmu.2022.852563)

<img src="https://upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/800px-Open_Access_logo_PLoS_transparent.svg.png" alt="drawing" width="50" align="left"/> &nbsp;&nbsp;&nbsp;This publication is available in **Open Access**! (Gold OA)

&nbsp;&nbsp;&nbsp;<a href="https://www.frontiersin.org/articles/10.3389/fimmu.2022.852563/pdf">Access it freely here</a>

